Sleep disorders, sleepiness and traffic safety: a public health menace
Braz. j. med. biol. res
; 39(7): 863-871, July 2006. tab
Artigo
em Inglês
| LILACS
| ID: lil-431569
Biblioteca responsável:
BR1.1
RESUMO
Sleep disorders are not uncommon and have been widely reported throughout the world. They have a profound impact on industrialized 24-h societies. Consequences of these problems include impaired social and recreational activities, increased human errors, loss of productivity, and elevated risk of accidents. Conditions such as acute and chronic insomnia, sleep loss, excessive sleepiness, shift-work, jet lag, narcolepsy, and sleep apnea warrant public health attention, since residual sleepiness during the day may affect performance of daily activities such as driving a car. Benzodiazepine hypnotics and zopiclone promote sleep, both having residual effects the following day including sleepiness and reduced alertness. In contrast, the non-benzodiazepine hypnotics zolpidem and zaleplon have no significant next-day residual effects when taken as recommended. Research on the effects of wakefulness-promoting drugs on driving ability is limited. Countermeasures for excessive daytime sleepiness have a limited effect. There is a need for a social awareness program to educate the public about the potential consequences of various sleep disorders such as narcolepsy, sleep apnea, shift-work-related sleep loss, and excessive daytime sleepiness in order to reduce the number of sleep-related traffic accidents.
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Contexto em Saúde:
ODS3 - Saúde e Bem-Estar
Problema de saúde:
Meta 3.6: Reduzir as mortes e traumatismos por acidentes de transito
Base de dados:
LILACS
Assunto principal:
Transtornos do Sono-Vigília
/
Condução de Veículo
/
Acidentes de Trânsito
Tipo de estudo:
Estudo de etiologia
/
Fatores de risco
Limite:
Humanos
Idioma:
Inglês
Revista:
Braz. j. med. biol. res
Assunto da revista:
Biologia
/
Medicina
Ano de publicação:
2006
Tipo de documento:
Artigo
/
Documento de projeto
País de afiliação:
Brasil
/
Canadá
/
Holanda
/
Estados Unidos
Instituição/País de afiliação:
Mount Sinai School of Medicine/US
/
Universidade Federal de São Paulo/BR
/
University of Toronto/CA
/
University of Utrecht/NL